nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—Hostility—Varenicline—nicotine dependence	0.0177	0.0274	CcSEcCtD
Phenytoin—Osteoporosis—Varenicline—nicotine dependence	0.0174	0.027	CcSEcCtD
Phenytoin—Parosmia—Varenicline—nicotine dependence	0.0151	0.0234	CcSEcCtD
Phenytoin—CYP2C18—Xenobiotics—CYP2A7—nicotine dependence	0.0142	0.0581	CbGpPWpGaD
Phenytoin—Nystagmus—Varenicline—nicotine dependence	0.0137	0.0212	CcSEcCtD
Phenytoin—Extrapyramidal disorder—Varenicline—nicotine dependence	0.013	0.0201	CcSEcCtD
Phenytoin—Scotoma—Varenicline—nicotine dependence	0.0129	0.0199	CcSEcCtD
Phenytoin—Gingivitis—Varenicline—nicotine dependence	0.0125	0.0193	CcSEcCtD
Phenytoin—Mydriasis—Varenicline—nicotine dependence	0.0123	0.019	CcSEcCtD
Phenytoin—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0112	0.0461	CbGpPWpGaD
Phenytoin—Tenderness—Varenicline—nicotine dependence	0.0112	0.0174	CcSEcCtD
Phenytoin—Chest discomfort—Varenicline—nicotine dependence	0.0111	0.0171	CcSEcCtD
Phenytoin—Accidental injury—Varenicline—nicotine dependence	0.0111	0.0171	CcSEcCtD
Phenytoin—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0108	0.0168	CcSEcCtD
Phenytoin—Thinking abnormal—Varenicline—nicotine dependence	0.0107	0.0165	CcSEcCtD
Phenytoin—Leukocytosis—Varenicline—nicotine dependence	0.0104	0.0161	CcSEcCtD
Phenytoin—Dysarthria—Varenicline—nicotine dependence	0.0103	0.016	CcSEcCtD
Phenytoin—Coordination abnormal—Varenicline—nicotine dependence	0.00996	0.0154	CcSEcCtD
Phenytoin—Pulmonary embolism—Varenicline—nicotine dependence	0.00978	0.0151	CcSEcCtD
Phenytoin—Hyperkalaemia—Varenicline—nicotine dependence	0.00961	0.0149	CcSEcCtD
Phenytoin—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00951	0.039	CbGpPWpGaD
Phenytoin—Salivary hypersecretion—Varenicline—nicotine dependence	0.0095	0.0147	CcSEcCtD
Phenytoin—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00941	0.0386	CbGpPWpGaD
Phenytoin—Photophobia—Varenicline—nicotine dependence	0.00918	0.0142	CcSEcCtD
Phenytoin—Urine output increased—Varenicline—nicotine dependence	0.00884	0.0137	CcSEcCtD
Phenytoin—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00876	0.036	CbGpPWpGaD
Phenytoin—Mental disability—Varenicline—nicotine dependence	0.00849	0.0131	CcSEcCtD
Phenytoin—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00849	0.0348	CbGpPWpGaD
Phenytoin—Lymphadenopathy—Varenicline—nicotine dependence	0.00832	0.0129	CcSEcCtD
Phenytoin—Primidone—GABRA4—nicotine dependence	0.00825	0.259	CrCbGaD
Phenytoin—Polyuria—Varenicline—nicotine dependence	0.00809	0.0125	CcSEcCtD
Phenytoin—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00794	0.0326	CbGpPWpGaD
Phenytoin—Deafness—Varenicline—nicotine dependence	0.00794	0.0123	CcSEcCtD
Phenytoin—Eye pain—Varenicline—nicotine dependence	0.00787	0.0122	CcSEcCtD
Phenytoin—CYP11B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00784	0.0322	CbGpPWpGaD
Phenytoin—Methylphenobarbital—GABRA4—nicotine dependence	0.00774	0.243	CrCbGaD
Phenytoin—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00774	0.0318	CbGpPWpGaD
Phenytoin—Injury—Varenicline—nicotine dependence	0.00773	0.012	CcSEcCtD
Phenytoin—Amnesia—Varenicline—nicotine dependence	0.00756	0.0117	CcSEcCtD
Phenytoin—Osteoarthritis—Varenicline—nicotine dependence	0.0071	0.011	CcSEcCtD
Phenytoin—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0071	0.011	CcSEcCtD
Phenytoin—Affect lability—Varenicline—nicotine dependence	0.00699	0.0108	CcSEcCtD
Phenytoin—Migraine—Varenicline—nicotine dependence	0.00699	0.0108	CcSEcCtD
Phenytoin—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00696	0.0286	CbGpPWpGaD
Phenytoin—Psychotic disorder—Varenicline—nicotine dependence	0.00693	0.0107	CcSEcCtD
Phenytoin—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00681	0.0279	CbGpPWpGaD
Phenytoin—Irritability—Varenicline—nicotine dependence	0.00678	0.0105	CcSEcCtD
Phenytoin—Urinary retention—Varenicline—nicotine dependence	0.00675	0.0105	CcSEcCtD
Phenytoin—Mood swings—Varenicline—nicotine dependence	0.00673	0.0104	CcSEcCtD
Phenytoin—SCN9A—midbrain—nicotine dependence	0.00664	0.0843	CbGeAlD
Phenytoin—Liver function test abnormal—Varenicline—nicotine dependence	0.00656	0.0102	CcSEcCtD
Phenytoin—Abdominal pain upper—Varenicline—nicotine dependence	0.00649	0.01	CcSEcCtD
Phenytoin—Hypokalaemia—Varenicline—nicotine dependence	0.00646	0.01	CcSEcCtD
Phenytoin—SLCO1C1—midbrain—nicotine dependence	0.00645	0.0818	CbGeAlD
Phenytoin—CYP11B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00644	0.0264	CbGpPWpGaD
Phenytoin—Breast disorder—Varenicline—nicotine dependence	0.00642	0.00994	CcSEcCtD
Phenytoin—Gastritis—Varenicline—nicotine dependence	0.00628	0.00973	CcSEcCtD
Phenytoin—Primidone—CHRNA4—nicotine dependence	0.00616	0.194	CrCbGaD
Phenytoin—Dysphagia—Varenicline—nicotine dependence	0.00614	0.0095	CcSEcCtD
Phenytoin—Asthma—Varenicline—nicotine dependence	0.00614	0.0095	CcSEcCtD
Phenytoin—Bronchitis—Varenicline—nicotine dependence	0.0059	0.00914	CcSEcCtD
Phenytoin—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00589	0.0242	CbGpPWpGaD
Phenytoin—SCN5A—cardiovascular system—nicotine dependence	0.00589	0.0747	CbGeAlD
Phenytoin—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00588	0.0241	CbGpPWpGaD
Phenytoin—CYP2C18—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0058	0.0238	CbGpPWpGaD
Phenytoin—Methylphenobarbital—CHRNA4—nicotine dependence	0.00578	0.182	CrCbGaD
Phenytoin—SCN1A—midbrain—nicotine dependence	0.00572	0.0725	CbGeAlD
Phenytoin—Photosensitivity reaction—Varenicline—nicotine dependence	0.0056	0.00867	CcSEcCtD
Phenytoin—Hyperglycaemia—Varenicline—nicotine dependence	0.00554	0.00857	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00542	0.0084	CcSEcCtD
Phenytoin—Conjunctivitis—Varenicline—nicotine dependence	0.00532	0.00824	CcSEcCtD
Phenytoin—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00526	0.0216	CbGpPWpGaD
Phenytoin—SCN2A—midbrain—nicotine dependence	0.00525	0.0665	CbGeAlD
Phenytoin—Hepatobiliary disease—Varenicline—nicotine dependence	0.00518	0.00801	CcSEcCtD
Phenytoin—Epistaxis—Varenicline—nicotine dependence	0.00516	0.00799	CcSEcCtD
Phenytoin—Sinusitis—Varenicline—nicotine dependence	0.00513	0.00795	CcSEcCtD
Phenytoin—Bradycardia—Varenicline—nicotine dependence	0.005	0.00774	CcSEcCtD
Phenytoin—Hypoaesthesia—Varenicline—nicotine dependence	0.00489	0.00757	CcSEcCtD
Phenytoin—Connective tissue disorder—Varenicline—nicotine dependence	0.00483	0.00748	CcSEcCtD
Phenytoin—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0048	0.0197	CbGpPWpGaD
Phenytoin—CYP2C18—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00477	0.0196	CbGpPWpGaD
Phenytoin—SCN8A—brain—nicotine dependence	0.00475	0.0603	CbGeAlD
Phenytoin—Erythema multiforme—Varenicline—nicotine dependence	0.00464	0.00719	CcSEcCtD
Phenytoin—SCN3A—midbrain—nicotine dependence	0.00461	0.0585	CbGeAlD
Phenytoin—Tinnitus—Varenicline—nicotine dependence	0.00458	0.00709	CcSEcCtD
Phenytoin—Immune system disorder—Varenicline—nicotine dependence	0.00444	0.00687	CcSEcCtD
Phenytoin—Chills—Varenicline—nicotine dependence	0.00441	0.00683	CcSEcCtD
Phenytoin—Flatulence—Varenicline—nicotine dependence	0.00421	0.00653	CcSEcCtD
Phenytoin—Dysgeusia—Varenicline—nicotine dependence	0.00419	0.00648	CcSEcCtD
Phenytoin—SCN9A—brain—nicotine dependence	0.00417	0.053	CbGeAlD
Phenytoin—Back pain—Varenicline—nicotine dependence	0.00414	0.00641	CcSEcCtD
Phenytoin—Muscle spasms—Varenicline—nicotine dependence	0.00411	0.00637	CcSEcCtD
Phenytoin—SLCO1C1—brain—nicotine dependence	0.00405	0.0514	CbGeAlD
Phenytoin—Tremor—Varenicline—nicotine dependence	0.00401	0.0062	CcSEcCtD
Phenytoin—Ill-defined disorder—Varenicline—nicotine dependence	0.00397	0.00614	CcSEcCtD
Phenytoin—Anaemia—Varenicline—nicotine dependence	0.00395	0.00612	CcSEcCtD
Phenytoin—Agitation—Varenicline—nicotine dependence	0.00393	0.00609	CcSEcCtD
Phenytoin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00391	0.016	CbGpPWpGaD
Phenytoin—Phenobarbital—CHRNA4—nicotine dependence	0.00389	0.122	CrCbGaD
Phenytoin—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00386	0.0158	CbGpPWpGaD
Phenytoin—Malaise—Varenicline—nicotine dependence	0.00386	0.00597	CcSEcCtD
Phenytoin—Vertigo—Varenicline—nicotine dependence	0.00384	0.00595	CcSEcCtD
Phenytoin—Syncope—Varenicline—nicotine dependence	0.00383	0.00594	CcSEcCtD
Phenytoin—Palpitations—Varenicline—nicotine dependence	0.00378	0.00585	CcSEcCtD
Phenytoin—Loss of consciousness—Varenicline—nicotine dependence	0.00376	0.00582	CcSEcCtD
Phenytoin—Cough—Varenicline—nicotine dependence	0.00373	0.00578	CcSEcCtD
Phenytoin—SCN4A—brain—nicotine dependence	0.00372	0.0472	CbGeAlD
Phenytoin—Convulsion—Varenicline—nicotine dependence	0.0037	0.00574	CcSEcCtD
Phenytoin—Hypertension—Varenicline—nicotine dependence	0.00369	0.00572	CcSEcCtD
Phenytoin—Arthralgia—Varenicline—nicotine dependence	0.00364	0.00564	CcSEcCtD
Phenytoin—Myalgia—Varenicline—nicotine dependence	0.00364	0.00564	CcSEcCtD
Phenytoin—Chest pain—Varenicline—nicotine dependence	0.00364	0.00564	CcSEcCtD
Phenytoin—CYP11B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00363	0.0149	CbGpPWpGaD
Phenytoin—Discomfort—Varenicline—nicotine dependence	0.0036	0.00557	CcSEcCtD
Phenytoin—SCN1A—brain—nicotine dependence	0.00359	0.0456	CbGeAlD
Phenytoin—Dry mouth—Varenicline—nicotine dependence	0.00356	0.00551	CcSEcCtD
Phenytoin—Infection—Varenicline—nicotine dependence	0.00347	0.00537	CcSEcCtD
Phenytoin—Shock—Varenicline—nicotine dependence	0.00343	0.00532	CcSEcCtD
Phenytoin—Nervous system disorder—Varenicline—nicotine dependence	0.00342	0.0053	CcSEcCtD
Phenytoin—CYP11B1—Biological oxidations—CYP2A7—nicotine dependence	0.00342	0.014	CbGpPWpGaD
Phenytoin—Thrombocytopenia—Varenicline—nicotine dependence	0.00342	0.00529	CcSEcCtD
Phenytoin—Tachycardia—Varenicline—nicotine dependence	0.00341	0.00527	CcSEcCtD
Phenytoin—Hyperhidrosis—Varenicline—nicotine dependence	0.00337	0.00522	CcSEcCtD
Phenytoin—CYP11B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00337	0.0139	CbGpPWpGaD
Phenytoin—Anorexia—Varenicline—nicotine dependence	0.00333	0.00515	CcSEcCtD
Phenytoin—SCN2A—brain—nicotine dependence	0.0033	0.0418	CbGeAlD
Phenytoin—Hypotension—Varenicline—nicotine dependence	0.00326	0.00505	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00318	0.00492	CcSEcCtD
Phenytoin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00317	0.013	CbGpPWpGaD
Phenytoin—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00316	0.013	CbGpPWpGaD
Phenytoin—Insomnia—Varenicline—nicotine dependence	0.00316	0.00489	CcSEcCtD
Phenytoin—Dyspnoea—Varenicline—nicotine dependence	0.00311	0.00482	CcSEcCtD
Phenytoin—Somnolence—Varenicline—nicotine dependence	0.0031	0.0048	CcSEcCtD
Phenytoin—Dyspepsia—Varenicline—nicotine dependence	0.00307	0.00476	CcSEcCtD
Phenytoin—Decreased appetite—Varenicline—nicotine dependence	0.00303	0.0047	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00301	0.00467	CcSEcCtD
Phenytoin—Fatigue—Varenicline—nicotine dependence	0.00301	0.00466	CcSEcCtD
Phenytoin—Constipation—Varenicline—nicotine dependence	0.00298	0.00462	CcSEcCtD
Phenytoin—CYP2B6—cardiovascular system—nicotine dependence	0.00297	0.0377	CbGeAlD
Phenytoin—CYP2C9—cardiovascular system—nicotine dependence	0.00294	0.0373	CbGeAlD
Phenytoin—SCN3A—brain—nicotine dependence	0.0029	0.0367	CbGeAlD
Phenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00289	0.0119	CbGpPWpGaD
Phenytoin—SCN5A—brain—nicotine dependence	0.00289	0.0366	CbGeAlD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00288	0.0118	CbGpPWpGaD
Phenytoin—Feeling abnormal—Varenicline—nicotine dependence	0.00288	0.00445	CcSEcCtD
Phenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00285	0.0117	CbGpPWpGaD
Phenytoin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00283	0.0116	CbGpPWpGaD
Phenytoin—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00279	0.0114	CbGpPWpGaD
Phenytoin—Urticaria—Varenicline—nicotine dependence	0.00277	0.00429	CcSEcCtD
Phenytoin—Body temperature increased—Varenicline—nicotine dependence	0.00276	0.00427	CcSEcCtD
Phenytoin—CYP2C18—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00269	0.011	CbGpPWpGaD
Phenytoin—Hypersensitivity—Varenicline—nicotine dependence	0.00257	0.00398	CcSEcCtD
Phenytoin—CYP2C18—Biological oxidations—CYP2A7—nicotine dependence	0.00253	0.0104	CbGpPWpGaD
Phenytoin—Asthenia—Varenicline—nicotine dependence	0.0025	0.00388	CcSEcCtD
Phenytoin—CYP2C18—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0025	0.0103	CbGpPWpGaD
Phenytoin—Pruritus—Varenicline—nicotine dependence	0.00247	0.00382	CcSEcCtD
Phenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00245	0.01	CbGpPWpGaD
Phenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00242	0.00992	CbGpPWpGaD
Phenytoin—Diarrhoea—Varenicline—nicotine dependence	0.00239	0.0037	CcSEcCtD
Phenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00234	0.00962	CbGpPWpGaD
Phenytoin—ALB—brain—nicotine dependence	0.00231	0.0293	CbGeAlD
Phenytoin—Dizziness—Varenicline—nicotine dependence	0.00231	0.00357	CcSEcCtD
Phenytoin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00229	0.0094	CbGpPWpGaD
Phenytoin—Vomiting—Varenicline—nicotine dependence	0.00222	0.00344	CcSEcCtD
Phenytoin—Rash—Varenicline—nicotine dependence	0.0022	0.00341	CcSEcCtD
Phenytoin—Dermatitis—Varenicline—nicotine dependence	0.0022	0.0034	CcSEcCtD
Phenytoin—Headache—Varenicline—nicotine dependence	0.00219	0.00339	CcSEcCtD
Phenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00218	0.00897	CbGpPWpGaD
Phenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00216	0.00885	CbGpPWpGaD
Phenytoin—Nausea—Varenicline—nicotine dependence	0.00207	0.00321	CcSEcCtD
Phenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00199	0.00818	CbGpPWpGaD
Phenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00198	0.00815	CbGpPWpGaD
Phenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00197	0.00807	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00192	0.00789	CbGpPWpGaD
Phenytoin—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00179	0.00733	CbGpPWpGaD
Phenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00177	0.00727	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00176	0.00723	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00175	0.00716	CbGpPWpGaD
Phenytoin—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00168	0.00691	CbGpPWpGaD
Phenytoin—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00166	0.00682	CbGpPWpGaD
Phenytoin—CYP2C8—brain—nicotine dependence	0.00163	0.0206	CbGeAlD
Phenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00161	0.00663	CbGpPWpGaD
Phenytoin—ABCB1—cardiovascular system—nicotine dependence	0.00159	0.0201	CbGeAlD
Phenytoin—CYP2B6—brain—nicotine dependence	0.00146	0.0185	CbGeAlD
Phenytoin—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00132	0.00542	CbGpPWpGaD
Phenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00131	0.00539	CbGpPWpGaD
Phenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0013	0.00532	CbGpPWpGaD
Phenytoin—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00129	0.0053	CbGpPWpGaD
Phenytoin—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00124	0.00511	CbGpPWpGaD
Phenytoin—ABCB1—midbrain—nicotine dependence	0.00124	0.0157	CbGeAlD
Phenytoin—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00123	0.00504	CbGpPWpGaD
Phenytoin—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00122	0.005	CbGpPWpGaD
Phenytoin—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0012	0.00493	CbGpPWpGaD
Phenytoin—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00112	0.00459	CbGpPWpGaD
Phenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00106	0.00437	CbGpPWpGaD
Phenytoin—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00105	0.00433	CbGpPWpGaD
Phenytoin—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00104	0.00427	CbGpPWpGaD
Phenytoin—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000998	0.0041	CbGpPWpGaD
Phenytoin—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000941	0.00386	CbGpPWpGaD
Phenytoin—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000928	0.00381	CbGpPWpGaD
Phenytoin—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00091	0.00374	CbGpPWpGaD
Phenytoin—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000858	0.00352	CbGpPWpGaD
Phenytoin—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000846	0.00347	CbGpPWpGaD
Phenytoin—ABCB1—brain—nicotine dependence	0.000779	0.00988	CbGeAlD
Phenytoin—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000713	0.00293	CbGpPWpGaD
Phenytoin—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0006	0.00246	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CYP2A7—nicotine dependence	0.000585	0.0024	CbGpPWpGaD
Phenytoin—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000566	0.00232	CbGpPWpGaD
Phenytoin—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000558	0.00229	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CYP2A7—nicotine dependence	0.000433	0.00178	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000383	0.00157	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000335	0.00138	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000288	0.00118	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.000213	0.000874	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000208	0.000854	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.00018	0.00074	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CYP2A7—nicotine dependence	0.000179	0.000736	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000161	0.00066	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000157	0.000645	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000147	0.000602	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.67e-05	0.000397	CbGpPWpGaD
